Testing Times For India’s Drug Patent Law
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - A couple of ongoing landmark developments, both involving the same drug, are putting India's patent law under a severe test and are expected to decide how multinational pharmaceutical firms will view the Indian market